MRI Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: August 22, 2022 Report Code: GDME1421EPD-ST

Select Item

Magnetic Resonance Imaging (MRI) utilizes radiofrequency and a strong magnetic field to generate clear and detailed images of internal organs and tissues. MRI is generally preferred for the diagnosis of brain and other neurological disorders.

The MRI systems pipeline market research report provides comprehensive information about the MRI systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report provides information about various pipeline products and their estimated approval dates.

Territory Outlook of the MRI Systems Pipeline Products Market

The key territories with products in the pipeline are the US, Europe, Israel, Canada, India, the UK, Japan, Pakistan, Singapore, South Africa, South Korea, Taiwan, China, and Australia. The US is the leading territory in the MRI systems pipeline products market followed by Europe and Israel.

MRI Systems Pipeline Products Market Analysis by Territories

MRI Systems Pipeline Products Market Analysis by Territories

For more territory insights, download a free report sample

Key Regulatory Paths for the MRI Systems Pipeline Products Market

The MRI systems pipeline report provides detailed insights into the pipeline products by a regulatory path including 510(k), CE, MDL, ICAC, UKCA, Ninsho, NMPA, TGA, HSA, BOPA, and MDITAC.

MRI Systems Pipeline Products Market Analysis by Regulatory Paths

MRI Systems Pipeline Products Market Analysis by Regulatory Paths

For more regulatory path insights, download a free report sample

Key Segments in the MRI Systems Pipeline Products Market

The key segments in the MRI systems pipeline products market are 1.5T MRI systems, 3T MRI systems, and 0.2T-1.2T MRI systems. 1.5T MRI systems account for the highest number of pipeline products in the market.

MRI Systems Pipeline Products Market Analysis by Segments

MRI Systems Pipeline Products Market Analysis by Segments

For more segment insights, download a free report sample

Key Companies in the MRI Systems Pipeline Products Market

Some of the key companies in the MRI systems pipeline products market are Advanced Imaging Research Inc, Advanced MRI Technologies, AHS Cancer Control Alberta, Anatomyworks LLC, ASG Superconductors SpA, Aspect Imaging Inc, Boston Children’s Hospital, Brigham and Women’s Hospital, C4 Imaging LLC, Cincinnati Children’s Hospital Medical Center, Clear Cut Medical Ltd., Collagen Medical LLC, DeepSpin GmbH, and Diagnosoft Inc.

MRI Systems Pipeline Products Market Report Overview

Key Territories The US, Europe, Israel, Canada, India, the UK, Japan, Pakistan, Singapore, South Africa, South Korea, Taiwan, China, and Australia
Key Regulatory Paths 510(k), CE, MDL, ICAC, UKCA, Ninsho, NMPA, TGA, HSA, BOPA, and MDITAC
Key Segments 1.5T MRI systems, 3T MRI systems, and 0.2T-1.2T MRI systems
Key Companies Advanced Imaging Research Inc, Advanced MRI Technologies, AHS Cancer Control Alberta, Anatomyworks LLC, ASG Superconductors SpA, Aspect Imaging Inc, Boston Children’s Hospital, Brigham and Women’s Hospital, C4 Imaging LLC, Cincinnati Children’s Hospital Medical Center, Clear Cut Medical Ltd., Collagen Medical LLC, DeepSpin GmbH, and Diagnosoft Inc

Scope

  • Extensive coverage of the MRI systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of MRI systems and lists all their pipeline projects
  • The coverage of pipeline products is based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of MRI systems under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Advanced Imaging Research Inc
Advanced MRI Technologies
AHS Cancer Control Alberta
Anatomyworks LLC
ASG Superconductors SpA
Aspect Imaging Inc
Boston Children's Hospital
Brigham and Women's Hospital
C4 Imaging, LLC
Cincinnati Children's Hospital Medical Center
Clear Cut Medical Ltd.
Collagen Medical LLC
DeepSpin GmbH
Diagnosoft Inc
Duke University
Focal Healthcare Inc
GE Global Research
GE Healthcare
General Electric Global Research Center
Georgetown University
Harvard University
Hebrew University of Jerusalem
Hugo W. Moser Research Institute at Kennedy Krieger Inc
Hyperfine Research Inc
Icahn School of Medicine at Mount Sinai
Intellidesign Pty Ltd
Johns Hopkins University
Leiden University
Leiden University Medical Center
Marvel Medtech LLC
Massachusetts General Hospital
Max Delbruck Center for Molecular Medicine
Medical College of Wisconsin
MicroMRI Inc
MRI Robotics LLC
National University of Science and Technology MiSiS
Neoscan Solutions GmbH
Neuro42 Inc
New York University School of Medicine
Ningbo Xingaoyi Medical Instruments Co. Ltd
Northwestern University
Oregon Health & Science University
Philips Healthcare
PhysioMRI Tech SL
Prism Clinical Imaging, Inc.
Promaxo Inc
Resonance Health Ltd
Robin Medical, Inc.
Shanghai United Imaging Healthcare Co Ltd
Siemens Healthineers AG
Stanford University
Superconducting Systems Inc
Tel Aviv University
The University of Manchester
The University of Nottingham
Time Medical, Inc.
Tornado Spectral Systems
University of Arizona
University of California Davis
University of California Los Angeles
University of Colorado
University of Colorado Boulder
University of Florida
University of Hong Kong
University of Illinois
University of Louisville
University of Michigan
University of Queensland
University of Saskatchewan
University of Strasbourg
University of Texas Southwestern Medical Center
University of Virginia
University of Washington
Vanderbilt University
Varian Medical Systems Inc
VisionQuest Biomedical LLC
Weinberg Medical Physics LLC
Weizmann Institute of Science
Wipro GE Healthcare Pvt Ltd
Wright State University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 9

|1.2 List of Figures 16

2 Introduction 17

2.1 MRI Systems Overview 17

3 Products under Development 18

3.1 MRI Systems – Pipeline Products by Stage of Development 18

3.2 MRI Systems – Pipeline Products by Segment 19

3.3 MRI Systems – Pipeline Products by Territory 20

3.4 MRI Systems – Pipeline Products by Regulatory Path 21

3.5 MRI Systems – Pipeline Products by Estimated Approval Date 22

3.6 MRI Systems – Ongoing Clinical Trials 23

4 MRI Systems – Pipeline Products under Development by Companies 24

4.1 MRI Systems Companies – Pipeline Products by Stage of Development 24

4.2 MRI Systems – Pipeline Products by Stage of Development 27

5 MRI Systems Companies and Product Overview 31

5.1 Advanced Imaging Research Inc Company Overview 31

5.1.1 Advanced Imaging Research Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.2 Advanced MRI Technologies Company Overview 32

5.2.1 Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview 32

5.3 AHS Cancer Control Alberta Company Overview 34

5.3.1 AHS Cancer Control Alberta Pipeline Products & Ongoing Clinical Trials Overview 34

5.4 Anatomyworks LLC Company Overview 35

5.4.1 Anatomyworks LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.5 ASG Superconductors SpA Company Overview 36

5.5.1 ASG Superconductors SpA Pipeline Products & Ongoing Clinical Trials Overview 36

5.6 Aspect Imaging Inc Company Overview 37

5.6.1 Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.7 Boston Children’s Hospital Company Overview 38

5.7.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 38

5.8 Brigham and Women’s Hospital Company Overview 39

5.8.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 C4 Imaging, LLC Company Overview 42

5.9.1 C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 42

5.10 Cincinnati Children’s Hospital Medical Center Company Overview 43

5.10.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 43

5.11 Clear Cut Medical Ltd. Company Overview 44

5.11.1 Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44

5.12 Collagen Medical LLC Company Overview 61

5.12.1 Collagen Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 61

5.13 DeepSpin GmbH Company Overview 62

5.13.1 DeepSpin GmbH Pipeline Products & Ongoing Clinical Trials Overview 62

5.14 Diagnosoft Inc Company Overview 63

5.14.1 Diagnosoft Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.15 Duke University Company Overview 64

5.15.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 64

5.16 Focal Healthcare Inc Company Overview 66

5.16.1 Focal Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.17 GE Global Research Company Overview 67

5.17.1 GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 67

5.18 GE Healthcare Company Overview 69

5.18.1 GE Healthcare Pipeline Products & Ongoing Clinical Trials Overview 69

5.19 General Electric Global Research Center Company Overview 72

5.19.1 General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview 72

5.20 Georgetown University Company Overview 73

5.20.1 Georgetown University Pipeline Products & Ongoing Clinical Trials Overview 73

5.21 Harvard University Company Overview 74

5.21.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 74

5.22 Hebrew University of Jerusalem Company Overview 75

5.22.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 75

5.23 Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview 76

5.23.1 Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.24 Hyperfine Research Inc Company Overview 78

5.24.1 Hyperfine Research Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.25 Icahn School of Medicine at Mount Sinai Company Overview 88

5.25.1 Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 88

5.26 Intellidesign Pty Ltd Company Overview 89

5.26.1 Intellidesign Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

5.27 Johns Hopkins University Company Overview 90

5.27.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 90

5.28 Leiden University Company Overview 92

5.28.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 92

5.29 Leiden University Medical Center Company Overview 93

5.29.1 Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 93

5.30 Marvel Medtech LLC Company Overview 94

5.30.1 Marvel Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 94

5.31 Massachusetts General Hospital Company Overview 97

5.31.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 97

5.32 Max Delbruck Center for Molecular Medicine Company Overview 100

5.32.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 100

5.33 Medical College of Wisconsin Company Overview 101

5.33.1 Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview 101

5.34 MicroMRI Inc Company Overview 103

5.34.1 MicroMRI Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.35 MRI Robotics LLC Company Overview 104

5.35.1 MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview 104

5.36 National University of Science and Technology MiSiS Company Overview 105

5.36.1 National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 105

5.37 Neoscan Solutions GmbH Company Overview 106

5.37.1 Neoscan Solutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 106

5.38 Neuro42 Inc Company Overview 107

5.38.1 Neuro42 Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.39 New York University School of Medicine Company Overview 108

5.39.1 New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 108

5.40 Ningbo Xingaoyi Medical Instruments Co. Ltd Company Overview 111

5.40.1 Ningbo Xingaoyi Medical Instruments Co. Ltd Pipeline Products & Ongoing Clinical Trials Overview 111

5.41 Northwestern University Company Overview 112

5.41.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 112

5.42 Oregon Health & Science University Company Overview 114

5.42.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 114

5.43 Philips Healthcare Company Overview 115

5.43.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 115

5.44 PhysioMRI Tech SL Company Overview 118

5.44.1 PhysioMRI Tech SL Pipeline Products & Ongoing Clinical Trials Overview 118

5.45 Prism Clinical Imaging, Inc. Company Overview 119

5.45.1 Prism Clinical Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119

5.46 Promaxo Inc Company Overview 120

5.46.1 Promaxo Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.47 Resonance Health Ltd Company Overview 121

5.47.1 Resonance Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

5.48 Robin Medical, Inc. Company Overview 122

5.48.1 Robin Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 122

5.49 Shanghai United Imaging Healthcare Co Ltd Company Overview 124

5.49.1 Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124

5.50 Siemens Healthineers AG Company Overview 125

5.50.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 125

5.51 Stanford University Company Overview 131

5.51.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 131

5.52 Superconducting Systems Inc Company Overview 134

5.52.1 Superconducting Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.53 Tel Aviv University Company Overview 135

5.53.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 135

5.54 The University of Manchester Company Overview 136

5.54.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 136

5.55 The University of Nottingham Company Overview 137

5.55.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 137

5.56 Time Medical, Inc. Company Overview 138

5.56.1 Time Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 138

5.57 Tornado Spectral Systems Company Overview 139

5.57.1 Tornado Spectral Systems Pipeline Products & Ongoing Clinical Trials Overview 139

5.58 University of Arizona Company Overview 140

5.58.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 140

5.59 University of California Davis Company Overview 141

5.59.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 141

5.60 University of California Los Angeles Company Overview 142

5.60.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 142

5.61 University of Colorado Company Overview 144

5.61.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 144

5.62 University of Colorado Boulder Company Overview 146

5.62.1 University of Colorado Boulder Pipeline Products & Ongoing Clinical Trials Overview 146

5.63 University of Florida Company Overview 147

5.63.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 147

5.64 University of Hong Kong Company Overview 148

5.64.1 University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 148

5.65 University of Illinois Company Overview 149

5.65.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 149

5.66 University of Louisville Company Overview 150

5.66.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 150

5.67 University of Michigan Company Overview 151

5.67.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 151

5.68 University of Queensland Company Overview 152

5.68.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 152

5.69 University of Saskatchewan Company Overview 153

5.69.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 153

5.70 University of Strasbourg Company Overview 154

5.70.1 University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 154

5.71 University of Texas Southwestern Medical Center Company Overview 155

5.71.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 155

5.72 University of Virginia Company Overview 156

5.72.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 156

5.73 University of Washington Company Overview 157

5.73.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 157

5.74 Vanderbilt University Company Overview 159

5.74.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 159

5.75 Varian Medical Systems Inc Company Overview 162

5.75.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 162

5.76 VisionQuest Biomedical LLC Company Overview 163

5.76.1 VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 163

5.77 Weinberg Medical Physics LLC Company Overview 164

5.77.1 Weinberg Medical Physics LLC Pipeline Products & Ongoing Clinical Trials Overview 164

5.78 Weizmann Institute of Science Company Overview 165

5.78.1 Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 165

5.79 Wipro GE Healthcare Pvt Ltd Company Overview 166

5.79.1 Wipro GE Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 166

5.80 Wright State University Company Overview 168

5.80.1 Wright State University Pipeline Products & Ongoing Clinical Trials Overview 168

6 MRI Systems- Recent Developments 169

6.1 Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs 169

6.2 Aug 03, 2022: Butterfly Network Reports Second Quarter 2022 Financial Results 169

6.3 Jul 29, 2022: Oxford Instruments Appoints Reshma Ramachandran as Independent Non-Executive Director 171

6.4 Jul 27, 2022: iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022 171

6.5 Jul 26, 2022: Siemens to Announce Third Quarter Results FY 2022 171

6.6 Jul 13, 2022: TeraRecon announces DocPanel signs Contract for Intuition Titanium, Reaffirming its Cardiothoracic Imaging Service Commitment 171

6.7 Jul 05, 2022: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2022 on Wednesday, July 27, 2022 172

6.8 Jun 29, 2022: Siemens invests in Volkswagen Electrify America 172

6.9 Jun 20, 2022: Single brain scan can diagnose Alzheimer’s disease 172

6.10 Jun 13, 2022: Canon Medical Systems Canada in partnership with Harley Street Healthcare Group Canada to launch integrated community diagnostic centres across Ontario 174

6.11 Jun 08, 2022: Ohio State appoints Dr. Chyke A. Doubeni to chief health equity officer role 174

6.12 Jun 08, 2022: Announcement of Preliminary Results for the year ended 31 March 2021 175

6.13 May 25, 2022: iCAD Announces CFO Transition 177

6.14 May 19, 2022: UZ Brussel first to treat breast cancer patients with new Brainlab deep inspiration breath hold with instant X-ray confirmation 177

6.15 May 13, 2022: Siemens to exit Russia over invasion of Ukraine; takes €600m hit 178

6.16 May 13, 2022: Butterfly Network to Present at the UBS Global Healthcare Conference 2022 178

6.17 May 12, 2022: Siemens Strong operational performance and growth ended March 31, 2022 179

6.18 May 12, 2022: Butterfly Network Strengthens Executive Team with Two C-Suite Appointments 181

6.19 May 12, 2022: Siemens Announces Q2 FY 2022 results 181

6.20 May 12, 2022: Strong operational performance and growth : Siemens AG 182

6.21 May 12, 2022: Earnings Release Q2 FY 2022 : Siemens AG 183

6.22 May 11, 2022: Promaxo to Showcase In-Office MRI System at AUA 2022 Annual Meeting 184

6.23 May 11, 2022: iCAD Reports Financial Results for First Quarter Ended March 31, 2022 185

6.24 May 11, 2022: Icad (ICAD) Reports Q1 Loss, Tops Revenue Estimates 186

6.25 May 09, 2022: Bruker launches novel 7 Tesla and

9.4 Tesla preclinical MRI magnets 186

6.26 May 05, 2022: Butterfly Network Reports First Quarter 2022 Financial Results 187

6.27 May 05, 2022: ViewRay Announces First Quarter 2022 Results 188

6.28 Apr 29, 2022: Concord Medical Files 2021 Annual Report on Form 20-F 189

6.29 Apr 25, 2022: New system order for Polarean Imaging 189

6.30 Apr 21, 2022: ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022 190

6.31 Apr 20, 2022: Butterfly Network Names Heather Getz as Chief Financial Officer 190

6.32 Apr 11, 2022: Promaxo Appoints Rob Korn as Global SVP Sales & Marketing 191

6.33 Apr 08, 2022: HeartVista Names Bruce Armstrong of Khosla Ventures to Board of Directors 191

6.34 Apr 06, 2022: RapidAI Announces Amit Phadnis as New Chief Innovation and Technology Officer 192

6.35 Apr 04, 2022: Dr. Elizabeth Plimack Appointed Deputy Director at Fox Chase Cancer Center 192

6.36 Mar 31, 2022: Wipro GE Healthcare: New factory launched under PLI to boost local manufacturing 193

6.37 Mar 30, 2022: Promaxo Announces Participation in the Piper Sandler 2nd Annual Virtual Private MedTech Symposium 194

6.38 Mar 29, 2022: ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Mini Conference 195

6.39 Mar 15, 2022: United Imaging receives contract from Vizient for its X-ray and magnetic resonance imaging systems 195

6.40 Mar 14, 2022: AMRA Medical, Daiichi Sankyo and NCNP joint MRI-based muscle research accepted for poster presentation at 2022 MDA Conference 195

6.41 Mar 10, 2022: ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022 196

6.42 Mar 10, 2022: SyntheticMR’s Board of Directors has resolved to carry out a directed new share issue of SEK 60 million, subject to subsequent approval by the Extraordinary General Meeting 196

6.43 Mar 01, 2022: Ultrasound scan can diagnose prostate cancer 198

6.44 Feb 28, 2022: iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2021 199

6.45 Feb 28, 2022: Bruker releases CCS-enabled TIMScore and TIMS DIA-NN 4D proteomics software 201

6.46 Feb 24, 2022: ViewRay Announces Fourth Quarter and Full Year 2021 Results 202

6.47 Feb 22, 2022: SyntheticMR : Year-End report January – December 2021 204

6.48 Feb 14, 2022: iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28 206

6.49 Feb 11, 2022: Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results 206

6.50 Feb 10, 2022: Siemens announces Earnings Release and Financial Results Q1 FY 2022 208

6.51 Feb 10, 2022: ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022 208

6.52 Feb 10, 2022: Very successful start to fiscal 2022 209

6.53 Feb 08, 2022: New vice chair appointed to PeaceHealth Board 210

6.54 Feb 02, 2022: Hitachi reports results for Q3 ended December 31, 2021 210

6.55 Feb 02, 2022: Hitachi reports change of executive chairman & CEO 211

6.56 Jan 31, 2022: RapidAI Announces Karim Karti as New CEO 211

6.57 Jan 25, 2022: ViewRay to Participate in the B. Riley Securities Oncology Conference 212

6.58 Jan 24, 2022: Philips announces Q4 and annual results 2021 212

6.59 Jan 11, 2022: Butterfly Network Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021 215

6.60 Dec 23, 2021: iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event 216

6.61 Dec 23, 2021: ViewRay to Participate in the 40th Annual J.P. Morgan Healthcare Conference 216

6.62 Dec 20, 2021: Elucid announces American Medical Association (AMA) instates CPT code for lipid-rich necrotic core quantification to assess atherosclerotic plaque stability 216

6.63 Dec 16, 2021: Ohio State researchers help develop new MRI, expanding access to life-saving imaging 217

6.64 Dec 10, 2021: INIFY Laboratories becomes an independent company 218

6.65 Dec 06, 2021: iCAD Announces CEO Transition 219

6.66 Nov 24, 2021: Siemens Limited announces Q4 FY 2021 results 219

6.67 Nov 15, 2021: Butterfly Network Reports Third Quarter 2021 Financial Results 220

6.68 Nov 09, 2021: iCAD Reports Financial Results for the Quarter Ended September 30, 2021 221

6.69 Nov 09, 2021: UTSW-led research identifies new imaging biomarkers that predict antidepressant response 223

6.70 Nov 04, 2021: ViewRay Reports Third Quarter 2021 Results 224

6.71 Nov 01, 2021: One Call Announces New Chief Operations Officer 226

6.72 Oct 29, 2021: Elucid Eyes big opportunity to save lives with software amidst major guideline changes 226

6.73 Oct 26, 2021: iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9 227

6.74 Oct 18, 2021: Bracco celebrates personalized and precision medicine innovations at RSNA 2021 227

6.75 Oct 18, 2021: Concord Medical is shortlisted for the “5G+Healthcare” Pilot Project 228

6.76 Oct 18, 2021: ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on October 28, 2021 228

6.77 Oct 14, 2021: ViewRay Announces Conference Call for Third Quarter 2021 Financial Results to be Held After Market on November 4, 2021 228

6.78 Oct 11, 2021: Philips launches Pediatric Coaching to enhance MR imaging patient experience for young children 229

6.79 Oct 11, 2021: Penn State College of Engineering: Wearable head scanner could allow for comfort, mobility during brain scans 230

6.80 Oct 05, 2021: AI helps rule out cancer in dense breasts 231

6.81 Oct 01, 2021: NIH to inject healthy bolus of data to sustain the future of AI for medical discoveries 231

6.82 Sep 29, 2021: Promaxo announces financing agreement with Kineo to Support Growth Plans 233

6.83 Sep 21, 2021: Farrer Park Hospital enhances dementia services to better guide management and care plan for people with dementia 233

6.84 Sep 16, 2021: Lynette Jackson appointed as new head of communications at Siemens 234

6.85 Sep 16, 2021: ViewRay to Partcipate in the Cantor Global Healthcare Conference 235

6.86 Sep 02, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 235

6.87 Sep 02, 2021: UCSF Radiology and Radiation Oncology researchers join forces to study HP 13C MRI in prostate cancer undergoing radiation therapy 235

7 Appendix 236

7.1 Methodology 236

7.2 About GlobalData 239

7.3 Contact Us 239

7.4 Disclaimer 239

Frequently asked questions

MRI Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

MRI Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports
Medical Devices
India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | August 2022
Medical Devices
Japan Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | August 2022
Medical Devices
New Zealand Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | August 2022
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at MRI Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live MRI Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more